Ocular Co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation

Effective pharmacotherapy during glaucoma treatment depends on interventions that reduce intraocular pressure (IOP) and retain the IOP lowering effect for sufficient time so as to reduce dosing frequency and enhance patient adherence. Combination anti-glaucoma therapy and dosage forms that increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Taka, Elissavet, Karavasili, Christina, Bouropoulos, Nikolaos, Moschakis, Thomas, Andreadis, Dimitrios D., Zacharis, Constantinos K., Fatouros, Dimitrios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344471/
https://www.ncbi.nlm.nih.gov/pubmed/32575910
http://dx.doi.org/10.3390/ph13060126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344471/
https://www.ncbi.nlm.nih.gov/pubmed/32575910
http://dx.doi.org/10.3390/ph13060126

Ejemplares similares